Literature DB >> 23385296

Farber lipogranulomatosis with predominant joint involvement mimicking juvenile idiopathic arthritis.

Mikhail M Kostik1, Irina A Chikova, Vladislav V Avramenko, Laly I Vasyakina, Emmanuelle Le Trionnaire, Vyacheslav G Chasnyk, Thierry Levade.   

Abstract

The case of a 10-year-old boy with Farber lipogranulomatosis with predominant joint involvement, subacute, laryngeal and tongue granulomas, microcytic anemia, elevated ESR and CRP, is presented. The boy had no signs of CNS and internal organ involvement. The disease manifested at 6 months; at 11 months the boy had widespread granulomatous polyarthritis with contractures, and juvenile idiopathic arthritis (JIA) was suggested. All antirheumatic therapies failed. Immunologic assessment revealed elevated serum interleukin-1β, increased T-helper, NK and CD25-positive cells, and circulating immune complexes. Our case with predominant rheumatologic manifestations illustrates a differential diagnosis of JIA.

Entities:  

Mesh:

Year:  2013        PMID: 23385296     DOI: 10.1007/s10545-012-9573-z

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  1 in total

1.  The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression.

Authors:  C M Li; J H Park; X He; B Levy; F Chen; K Arai; D A Adler; C M Disteche; J Koch; K Sandhoff; E H Schuchman
Journal:  Genomics       Date:  1999-12-01       Impact factor: 5.736

  1 in total
  6 in total

1.  Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy.

Authors:  Shaalee Dworski; Ping Lu; Aneal Khan; Bruno Maranda; John J Mitchell; Rossella Parini; Maja Di Rocco; Boris Hugle; Makoto Yoshimitsu; Bo Magnusson; Balahan Makay; Nur Arslan; Norberto Guelbert; Karoline Ehlert; Andrea Jarisch; Janet Gardner-Medwin; Rawane Dagher; Maria Teresa Terreri; Charles Marques Lorenco; Lilianna Barillas-Arias; Pranoot Tanpaiboon; Alexander Solyom; James S Norris; Xingxuan He; Edward H Schuchman; Thierry Levade; Jeffrey A Medin
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-12-01       Impact factor: 5.187

2.  Rare Diseases in Glycosphingolipid Metabolism.

Authors:  Hongwen Zhou; Zhoulu Wu; Yiwen Wang; Qinyi Wu; Moran Hu; Shuai Ma; Min Zhou; Yan Sun; Baowen Yu; Jingya Ye; Wanzi Jiang; Zhenzhen Fu; Yingyun Gong
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease.

Authors:  Claudia Cozma; Marius-Ionuț Iurașcu; Sabrina Eichler; Marina Hovakimyan; Oliver Brandau; Susanne Zielke; Tobias Böttcher; Anne-Katrin Giese; Jan Lukas; Arndt Rolfs
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

Review 4.  Acid ceramidase deficiency: Farber disease and SMA-PME.

Authors:  Fabian P S Yu; Samuel Amintas; Thierry Levade; Jeffrey A Medin
Journal:  Orphanet J Rare Dis       Date:  2018-07-20       Impact factor: 4.123

5.  Acid Sphingomyelinase Deficiency Ameliorates Farber Disease.

Authors:  Nadine Beckmann; Katrin Anne Becker; Stephanie Kadow; Fabian Schumacher; Melanie Kramer; Claudine Kühn; Walter J Schulz-Schaeffer; Michael J Edwards; Burkhard Kleuser; Erich Gulbins; Alexander Carpinteiro
Journal:  Int J Mol Sci       Date:  2019-12-11       Impact factor: 5.923

6.  A case of Myhre syndrome mimicking juvenile scleroderma.

Authors:  Barbara Jensen; Rebecca James; Ying Hong; Ebun Omoyinmi; Clarissa Pilkington; Neil J Sebire; Kevin J Howell; Paul A Brogan; Despina Eleftheriou
Journal:  Pediatr Rheumatol Online J       Date:  2020-09-11       Impact factor: 3.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.